Immune Omicron BQ Variations Are Increasing In The U.S.
As stated by the Centers for Disease Control and Prevention, Omicron subvariants will soon account for the bulk of new COVID infections in the...
Cancer Medicine Prices Jump 53% In Five Years In The U.S
According to new research by Katie Porter, U.S. Democratic Representative and a consumer bankruptcy law professor vying for re-election in California, the cost of...
Report Indicates UK £62bn Behind In Global R&D Investment
According to a recent data study by the Institute for Public Policy Research, the UK's share of worldwide research and development (R&D) spending has...
Once More, M&As In Biotechechnology Industry Are Thriving
Deals can be just as significant in the drug development industry as scientific advancements. Without mergers and acquisitions, many of today's most significant pharmaceuticals—from...
Ancient Viral DNA Guards Against Infections In Human Genome
According to new research, ancient infections that left viral DNA in human genomes act as antivirals to shield human cells from some modern viruses.
A...
Omicron Subvariants Withstand Essential Antibody Treatments
The White House issued a warning this week that HIV patients, kidney transplant recipients, and other immunocompromised people are particularly susceptible to COVID this...
Research And Development In UK Falls Behind Other Nations
According to a new report by IPPR, the UK's percentage of worldwide research and development (R&D) spending has decreased by 5% since 2014. Even...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...